Increased circulating CD31+/CD42- microparticles are associated with impaired systemic artery elasticity in healthy

Jie-Mei Wang1, Yi-Jun Huang, Yan Wang

  • 1Department of Cardiology, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.

Abstract

Insights

Circulating CD31+/CD42- microparticles (MPs) correlate with reduced artery elasticity in healthy individuals. Elevated MP levels may indicate impaired vascular health and serve as a novel biomarker for clinical evaluation.

Area of Science:

  • Cardiovascular Research
  • Biomarker Discovery
  • Endothelial Function

Background:

  • Endothelial dysfunction is linked to impaired artery elasticity in various diseases.
  • CD31+/CD42- microparticles (MPs) are emerging markers of endothelial injury.
  • The relationship between physiological CD31+/CD42- MPs and arterial properties is not well-established.

Purpose of the Study:

  • To investigate the correlation between circulating CD31+/CD42- MPs and systemic artery elasticity in healthy subjects.
  • To determine if CD31+/CD42- MPs are associated with measures of arterial stiffness.

Main Methods:

  • Evaluated brachia-ankle pulse-wave velocity (baPWV) and large/small artery elasticity indices using noninvasive pulse-wave analysis.
  • Quantified circulating CD31+/CD42- MPs via flow cytometry in healthy participants.

Main Results:

  • Positive correlation found between CD31+/CD42- MPs and baPWV (r = 0.371, P = .008).
  • Negative correlation observed between CD31+/CD42- MPs and large-artery (r = -0.294, P = .037) and small-artery (r = -0.310, P = .027) elasticity indices.
  • Multivariate analysis identified CD31+/CD42- MPs as significant contributors to impaired systemic artery elasticity.

Conclusions:

  • Circulating CD31+/CD42- MPs are closely associated with impaired systemic artery elasticity in healthy individuals.
  • CD31+/CD42- MPs serve as a biomarker for endothelial dysfunction and vascular injury.
  • These MPs may represent a novel surrogate marker for clinical assessment of vascular damage.

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...